Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Early Feasibility Study of the Edwards APTURE Transcatheter Shunt System

NCT: NCT07858799 · RECRUITING

NCT IDNCT07858799
StatusRECRUITING
Start Date2026-10
Completion2032-03
SponsorEdwards Lifesciences (INDUSTRY)
First posted
Last updated

Brief Summary

The objectives of this early feasibility study are to: evaluate initial clinical safety, device functionality, and effectiveness of the APTURE system for treatment of symptomatic HFrEF patients with elevated LAP, provide guidance for future clinical study and system designs utilizing the APTURE system.

Frequently Asked Questions

What is Early Feasibility Study of the Edwards APTURE Transcatheter Shunt System?

Early Feasibility Study of the Edwards APTURE Transcatheter Shunt System is a clinical trial registered under NCT07858799. Current status: RECRUITING.

What is the status of NCT07858799?

The current status of NCT07858799 (Early Feasibility Study of the Edwards APTURE Transcatheter Shunt System) is: RECRUITING.

When did Early Feasibility Study of the Edwards APTURE Transcatheter Shunt System start?

Early Feasibility Study of the Edwards APTURE Transcatheter Shunt System started on 2026-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑